China Resources Pharmaceutical (03320.HK): China Resources Pharmaceutical Commercial initiates pre-disclosure of capital increase for Beijing Stock Exchange bidding

Zhito Finance APP News: China Resources Pharmaceutical (03320.HK) announced that its non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial) proposes to issue new shares through a legally established equity exchange via public tender in accordance with the relevant provisions of the Measures for the Supervision and Administration of Enterprise State-Owned Asset Transactions. On October 16, 2026, the pre-bidding procedures related to the potential issuance were launched through the Beijing Equity Exchange. China Resources Pharmaceutical Commercial published a pre-disclosure application regarding capital increase information on the website of the Beijing Equity Exchange on October 16, 2026 for the pre-bidding procedures.